- Home
- ICLR vs CNC Comparison
ICLR vs CNC Comparison
Compare ICLR & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- CNC
- Stock Information
- Founded
- ICLR 1990
- CNC 1984
- Country
- ICLR Ireland
- CNC United States
- Employees
- ICLR N/A
- CNC N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- CNC Medical Specialities
- Sector
- ICLR Health Care
- CNC Health Care
- Exchange
- ICLR Nasdaq
- CNC Nasdaq
- Market Cap
- ICLR 14.3B
- CNC 14.3B
- IPO Year
- ICLR 1998
- CNC 2001
- Fundamental
- Price
- ICLR $178.10
- CNC $34.11
- Analyst Decision
- ICLR Buy
- CNC Hold
- Analyst Count
- ICLR 15
- CNC 16
- Target Price
- ICLR $211.36
- CNC $37.07
- AVG Volume (30 Days)
- ICLR 1.0M
- CNC 9.5M
- Earning Date
- ICLR 10-22-2025
- CNC 10-29-2025
- Dividend Yield
- ICLR N/A
- CNC N/A
- EPS Growth
- ICLR N/A
- CNC N/A
- EPS
- ICLR 7.47
- CNC 4.07
- Revenue
- ICLR $8,102,602,000.00
- CNC $159,673,000,000.00
- Revenue This Year
- ICLR N/A
- CNC $30.96
- Revenue Next Year
- ICLR $1.68
- CNC N/A
- P/E Ratio
- ICLR $24.08
- CNC $8.38
- Revenue Growth
- ICLR N/A
- CNC 10.73
- 52 Week Low
- ICLR $125.10
- CNC $25.08
- 52 Week High
- ICLR $242.72
- CNC $70.11
- Technical
- Relative Strength Index (RSI)
- ICLR 45.22
- CNC 45.20
- Support Level
- ICLR $173.47
- CNC $33.00
- Resistance Level
- ICLR $198.30
- CNC $36.53
- Average True Range (ATR)
- ICLR 7.63
- CNC 1.23
- MACD
- ICLR -1.08
- CNC -0.50
- Stochastic Oscillator
- ICLR 18.63
- CNC 17.68
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.